Shared on 30 Oct 25
Analysts have maintained their price target for NOCIL at ₹200.75, reflecting steady confidence in the company's outlook as incremental changes in discount rate and profit margin remain negligible. What's in the News The Board of Directors of NOCIL will meet on October 31, 2025 to consider, approve, and take on record the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, along with the limited review report and other business matters (Key Developments).
Shared on 16 Oct 25
Fair value Decreased 2.25%Analysts have slightly revised their price target for NOCIL downward, decreasing it from ₹205.38 to ₹200.75. This adjustment is based on updated expectations around revenue growth, profit margin, and risk profile.
Shared on 23 Apr 25
Fair value Decreased 0.41%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 3.50%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 0.47%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Increased 12%AnalystConsensusTarget has decreased revenue growth from 17.4% to 12.1% and increased future PE multiple from 25.2x to 29.0x.